The angpt2 gene was shown to be over-expressed in patients with highly vascular-active ROP [55] and was only up-regulated in plasmalogen-deficient mice, suggesting a more severe phenotype in mice with plasmalogen deficiency than in those with retinal iPLA2 inhibition. This evidence concerns the gene ANGPT2 and retinopathy of prematurity.